Uncertainty about President Donald Trump's economic policies sent the markets tumbling to a sharply lower close with the Dow plunging 125 points to 19,845. Nasdaq lost 5 points to 5,607.
On the upside
Bargain hunters lifted shares of Diana Containerships (Nasdaq: DCIX).
The invalidation of Teva Pharmaceutical's (NYSE: TEVA) patent infringement suit lifted shares of generic drug maker Momenta Pharmaceuticals (Nasdaq: MNTA).
Northland Securities affirmed its Outperform rating on Cynosure (Nasdaq: CYNO).
On the downside
Tenax Therapeutics (Nasdaq: TENX) reported disappointing results from a Phase 3 LEVO-CTS trial.
Dimension Therapeutics (Nasdaq: DMTX) reported that five out of six patients in a Phase 1/2 study of DTX101 to treat adults with moderate/severe to severe hemophilia B experienced elevations in alanine aminotransferase.
Roadrunner Transportation Systems (NYSE: RRTS) must restate annual and quarterly financial reports for 2014, 2015 and 2016 due to accounting discrepancies.
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE and by nearly 5 to 3 on Nasdaq. The broader S&P 500 index slipped 2 points to 2,278. Bitcoin soared $29 to $945.
